EquityZen Growth Technology Fund LLC - Series 1667
Raised
$650K
Investors
9
Min Invest
$10,059
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1667 is a Delaware-based pooled investment vehicle filed by EquityZen Advisors and Philip Haslett, raising $650K from 9 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This series is part of the EquityZen platform, which operates 150+ related EDGAR entities focused on private equity secondaries and pre-IPO access.
This filing represents a typical special purpose vehicle structure within the private equity secondary market, utilizing the standard 506(b) exemption paired with 3(c)(1) to remain outside Investment Company Act registration. The $10K minimum investment and sub-$1M raise size align with EquityZen's retail-accessible SPV model for accessing private company shares.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Equityzen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
